伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,321件～3,340件を表示しています。
[1] ・・・ [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] ・・・ [848]

(3S,5R,6S)-2-(((1S,4aR,5S,7aS)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Aucubin 479-98-1 C15H22O9 346.334 346.1264

6642. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 5.23 ± 0.93 h 2.83 ± 0.75 h 131.3 ± 26.3 ng/mL 958.8 ± 241.7 ng/mLxh 978.3 ± 251.0 ng/mLxh 0-t 0― Geniposide 代謝パラメータ

6643. [TOPICS] 『2011 (探索研究)』

2011 (探索研究) 探索研究論文

6644. [生薬成分の代謝] 代謝マップ『Asarinin』

Asarinin 腸内細菌 4-((1S,3aR,4R,6aR)-4-(benzo[d][1,3]dioxol-5-yl)hexahydrofuro[3,4-c]furan-1-yl)benzene-1,2-diol,Asarinin,4-(((3R,4R,5R)-5-(benzo[d][1,3]dioxol-5-yl)-4-(hydroxymethyl)tetrahydrofuran-3-yl)

6645. [生薬成分の代謝] 代謝パラメータ『Oral administration 』

Oral administration 50 mg/kg N.D. N.D. N.D. 0-10 h N.D. : not detected. Saikosaponin b1 代謝パラメータ

6646. [TOPICS] 『2011 (知的クラスター)』

2011 (知的クラスター) 知的クラスター論文 - Kageyama-Yahara N., Wang X., Katagiri T., Wang P., Yamamoto T., Tominaga M., Kadowaki M.: Suppression of phospholipase Cγ1 phosphorylation by cinnamaldehyde inhibits antigen

6647. [TOPICS] 『2019 (探索研究)』

2019 (探索研究) 探索研究論文 - Fukuchi M., Okuno Y., Nakayama H., Nakano A., Mori H., Mitazaki S., Nakano Y., Toume K., Jo M., Takasaki I., Watanabe K., Shibahara N., Komatsu K., Tabuchi A., Tsuda M.: Screening

6648. [TOPICS] 『2021 (探索研究)』

2021 (探索研究) 探索研究論文 - Rahman M. A., Ueda K., Honda T.: A Traditional Chinese medicine, maoto, suppresses hepatitis B virus production. Front. Cell. Infect. Microbiol., 10:581345 (2021). doi:

6649. [生薬成分の代謝] 代謝物『Aucubigenin』

(4aR,5S,7aS)-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1,5-diol Aucubigenin 64274-28-8 C9H12O4 184.192 184.0736 185.0814 183.0657 Aucubin 代謝物

6650. [TOPICS] 『2012 (探索研究)』

2012 (探索研究) 探索研究論文 - Ishimoto T., Mano H., Ozawa T., Mori H.: Measuring CREB activation using bioluminescent probes that detect KID-KIX interaction in living cells. Bioconjug. Chem., 23(5):923-932 (20

6651. [TOPICS] 『2017 (探索研究)』

2017 (探索研究) 探索研究論文 - Hishiki T., Kato F., Miura T., Tajima S., Toume K., Umezaki M., Takasaki T.: Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits late step in Dengue virus lifecycle.

6652. [生薬成分の代謝] 代謝物『Quinic acid』

(1S,3R,4S,5R)-1,3,4,5-tetrahydroxycyclohexanecarboxylic acid Quinic acid 77-95-2 C7H12O6 192.169 192.0634 193.0712 191.0556 Chlorogenic acid 代謝物

6653. [生薬成分の代謝] 代謝物『Chlorogenic acid』

(1S,3R,4R,5R)-3-(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4,5-trihydroxycyclohexanecarboxylic acid Chlorogenic acid 327-97-9 C16H18O9 354.314 354.0951 355.1029 353.0873 Chlorogenic acid 代謝物

6654. [生薬成分の代謝] 代謝物『Cholesterol』

(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol Cholesterol 57-88-5 C27H46O 386.662 386.3549 387.

6655. [生薬成分の代謝] 代謝物『(3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol』

(3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol (3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)hexadecahydro-1H-cycl

6656. [生薬成分の代謝] 代謝物『Cholic acid』

(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid Cholic acid 81-25-4 C24H40O5 408.579 408.2876 409.2954 407.27

6657. [生薬成分の代謝] 代謝物『(R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid』

(R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylh

6658. [生薬成分の代謝] 代謝物『(+)-Enterodiol (2S, 3S)』

(2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (+)-Enterodiol (2S, 3S) C18H22O4 302.37 302.1518 303.1596 301.144 Enterodiol 代謝物

6659. [生薬成分の代謝] 代謝物『(2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol』

(2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol (2S,3S)-2,3-bis(3-hydroxybenzyl)butane-1,4-diol C18H22O4 302.37 302.1518 303.1596 301.144 Enterodiol 代謝物

6660. [生薬成分の代謝] 代謝物『K-Strophanthoside』

(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-(((2R,4S,5R,6R)-4-methoxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl

[1] ・・・ [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] ・・・ [848]
全16,951件中、3,321件～3,340件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究